What is CAGE Code U18L4?

U18L4 is the unique identifier used by NATO Organizations to reference the physical entity known as Summit (Oxford) Limited located at 136A Eastern Avenue, Milton Park, Abingdon, Oxfordshire, OX14 4SB, United Kingdom.

Who is CAGE Code U18L4?

U18L4 refers to Summit (Oxford) Limited located at 136A Eastern Avenue, Milton Park, Abingdon, Oxfordshire, OX14 4SB, United Kingdom.

Where is CAGE Code U18L4 Located?

CAGE Code U18L4 is located in Abingdon, United Kingdom.

Summit (Oxford) Limited

CAGE Code: U18L4

NCAGE Code: U18L4

Status: Active

Type: Commercial Service Contractor

Summary

Summit (Oxford) Limited is an Active Commercial Service Contractor with the Cage Code U18L4.

Address

136A Eastern Avenue, Milton Park
Abingdon
Oxfordshire
OX14 4SB
United Kingdom

Points of Contact

No Points of Contact...

Related Information

No Related Information...

Frequently Asked Questions (FAQ) for CAGE U18L4

What is CAGE Code U18L4?: U18L4 is the unique identifier used by NATO Organizations to reference the physical entity known as Summit (Oxford) Limited located at 136A Eastern Avenue, Milton Park, Abingdon, Oxfordshire, OX14 4SB, United Kingdom.
Who is CAGE Code U18L4?: U18L4 refers to Summit (Oxford) Limited located at 136A Eastern Avenue, Milton Park, Abingdon, Oxfordshire, OX14 4SB, United Kingdom.
Where is CAGE Code U18L4 Located?: CAGE Code U18L4 is located in Abingdon, United Kingdom.

Contracting History for CAGE U18L4 Most Recent 25 Records

HHSO100201700014C
The Purpose Of This No Cost Bilateral Modification Is To Remove Hhsar Clause 352.232-71: Electronic Submission Of Payment Requests
30 Jun 2022: Barda - Aspr / Daappo / Barda Dcma; Department Of Health And Human Services (Hhs); $62,378,054.00
HHSO100201700014C
The Purpose Of This No Cost Bilateral Modification Is To (1) Incorporate Hhsar Clause 352.232-71: Electronic Submission Of Payment Requests, (2) Extend The Period Of Performance, (3) Change The Appointed Cor, (4) Change The Co, (5) Approve Replacemen
29 Apr 2022: Barda - Aspr / Daappo / Barda Dcma; Department Of Health And Human Services (Hhs); $62,378,054.00
HHSO100201700014C
Development Of Ridinilazole To Combat Clostridium Difficle
17 Jun 2019: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $53,588,496.00
HHSO100201700014C
Igf::Ot::Igf
18 Jan 2019: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $43,967,000.00
HHSO100201700014C
Igf::Ot::Igf
29 Mar 2018: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $43,967,000.00
HHSO100201700014C
Development Of Ridinilazole To Combat Clostridium Difficle
10 Sep 2020: Office Of Acq&Mgmt Policy; Department Of Health And Human Services (Hhs); $62,378,054.00
HHSO100201700014C
Development Of Ridinilazole To Combat Clostridium Difficle
21 Jan 2020: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $62,378,054.00
HHSO100201700014C
Drugs And Biologicals
5 Sep 2017: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $43,967,000.00